Stay updated on Pembrolizumab for ALL MRD Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.

Latest updates to the Pembrolizumab for ALL MRD Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new note states that publications are automatically filled from PubMed and the page now shows revision v3.3.2, replacing the previous wording and revision v3.2.0.SummaryDifference0.1%

- Check16 days agoChange DetectedA site-wide notice about government funding lapse and potential delays has been removed. This notice previously warned that information on the page may not be up to date.SummaryDifference0.4%

- Check31 days agoChange DetectedNo significant changes to core study content (title, objectives, eligibility criteria, endpoints) are detected between screenshots; observed differences appear to be cosmetic or formatting related. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check52 days agoChange DetectedPage updated to version v3.2.0 and now includes a government operations status notice; older version tag v3.1.0 was removed.SummaryDifference3%

- Check67 days agoChange Detected- Added new broader topics on lymphomas and virus infections, and updated revision to v3.1.0. - Removed two specific leukemia-related items and an older revision tag (v3.0.2).SummaryDifference2%

- Check81 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab for ALL MRD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for ALL MRD Clinical Trial page.